February 13, 2018
The Eleventh Circuit failed to consider several issues when it ruled in favor of Amgen Inc., Pfizer Inc. and Wyeth Inc. in a lawsuit brought by a woman claiming their arthritis drug, Enbrel, caused severe infections, according to a motion for rehearing filed Monday.
January 22, 2018
The Eleventh Circuit affirmed on Monday a lower court's decision to grant Amgen Inc., Pfizer Inc. and Wyeth Inc. a quick win in a suit alleging their arthritis drug Enbrel caused a woman severe infections, finding the woman's doctor knew about the drug's risks, so she can't claim the drugmakers didn't warn her.